Data as of Jan 30
| +0.26 / +9.15%|
The 1 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a -19.35% decrease from the last price of 3.10.
The current consensus among 1 polled investment analysts is to Buy stock in CorMedix Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.